NCT00003342View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 1997

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Interventions
BIOLOGICAL

filgrastim

DRUG

carboplatin

DRUG

doxorubicin hydrochloride

DRUG

gemcitabine hydrochloride

DRUG

paclitaxel

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

New York Weill Cornell Cancer Center at Cornell University, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003342 - Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer | Biotech Hunter | Biotech Hunter